Jenburkt Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 4.41 Cr
- Company Age 39 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.78 Cr
- Satisfied Charges ₹ 11.42 Cr
- Revenue Growth 10.04%
- Profit Growth 10.36%
- Ebitda 11.42%
- Net Worth 4.27%
- Total Assets -0.80%
About Jenburkt Pharmaceuticals
Jenburkt Pharmaceuticals Ltd (JPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 10 June 1985 and has a history of 39 years and nine months. Its registered office is in Mumbai, Maharashtra, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 524731.
The Corporate was formerly known as Jen Burkt Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 4.41 Cr.
The company currently has active open charges totaling ₹6.78 Cr. The company has closed loans amounting to ₹11.42 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Jenburkt Pharmaceuticals Ltd India are Ashish Shah as COMPANY SECRETARY and Dilip Bhuta as Cfo. Hina Mehta, Dilip Bhuta, Ashish Bhuta, and Three other members serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
L24230MH1985PLC036541
- Company No.
036541
- Stock Symbol
BSE : 524731
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
10 Jun 1985
- Date of AGM
30 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Mumbai
Industry
Pharma
What products or services does Jenburkt Pharmaceuticals Ltd offer?
Jenburkt Pharmaceuticals Ltd offers a wide range of products and services, including Diabetic Medicines, Vitamins, Minerals & Antioxidants.
Jenburkt Pharmaceuticals Ltd
Explore comprehensive data for Jenburkt Pharmaceuticals Ltd, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Jenburkt Pharmaceuticals?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashish Shah  | Company Secretary | 01-Dec-1999 | Current |
| Dilip Bhuta | CFO | 01-Apr-2019 | Current |
| Ashish Bhuta | Managing Director | 02-Jun-2007 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Krishnan Subharaman | Director | 28-May-2024 | Current |
| Hina Mehta | Director | 28-Mar-2020 | Current |
| Pankaj Dantwala | Director | 28-May-2024 | Current |
| Sumit Thakkar | Director | 26-Jul-2023 | Current |
Financial Performance of Jenburkt Pharmaceuticals.
Jenburkt Pharmaceuticals Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 10.04% increase. The company also saw a substantial improvement in profitability, with a 10.36% increase in profit. The company's net worth moved up by a moderate rise of 4.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jenburkt Pharmaceuticals?
In 2023, Jenburkt Pharmaceuticals had a promoter holding of 47.56% and a public holding of 52.44%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bhuta Holdings Private LimitedDilip Bhuta and Ashish Bhuta are mutual person
- Clover Infoservices Private Limited
Pankaj Dantwala is a mutual person
- Kalzoom Technologies Private Limited
Pankaj Dantwala is a mutual person
- Kalzoom Management Service Technologies Private Limited
Pankaj Dantwala is a mutual person
- Natarajan Empowerment Foundation
Pankaj Dantwala is a mutual person
Charges (Loans)
Open Charges
₹6.78 Cr
Satisfied Charges
₹11.42 Cr
Charges Breakdown by Lending Institutions
- Others : 6.78 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Nov 2022 | Others | ₹0.10 M | Open |
| 21 Nov 2022 | Others | ₹0.20 M | Open |
| 21 Nov 2022 | Others | ₹2.00 Cr | Open |
| 28 Aug 2019 | Others | ₹4.75 Cr | Open |
| 02 Dec 2022 | Others | ₹3.00 Cr | Satisfied |
How Many Employees Work at Jenburkt Pharmaceuticals?
Jenburkt Pharmaceuticals has a workforce of 765 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jenburkt Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jenburkt Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Jenburkt Pharmaceuticals
Recent activity within the organization
- Charges
A charge registered on 21 Oct 2022 via Charge ID 100627860 with Others was fully satisfied on 22 Jan 2025.
- Annual General Meeting
Jenburkt Pharmaceuticals Ltd last Annual general meeting of members was held on 30 Jul 2024 as per latest MCA records.
- Director Appointment
Krishnan Subharaman was appointed as a Director was appointed as a Director on 28 May 2024 & has been associated with this company since 9 months 15 days .
- Director Appointment
Pankaj Arun Dantwala was appointed as a Director was appointed as a Director on 28 May 2024 & has been associated with this company since 9 months 15 days .
- Balance Sheet
Jenburkt Pharmaceuticals Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
- Charges
A charge with Others of Rs. 2.00 Cr registered on 21 Nov 2022 with Charge ID 100652317 was modified on 19 Dec 2023.
Recent News, Updates & Announcement
- Jenburkt Pharma Announces 22.37% Higher Buyback Price of Rs. 576 per Share Through Tender Offer Managed by Yes Securities.
When Jenburkt Pharma wants to buy back their shares, they're offering a price of Rs. 576 per share, which is 22.37% higher than the current market price. This buyback is for 208333 shares and will be done through a Tender Offer. The total cost is Rs. 12 Crore, but doesn't include extra expenses. The Board formed a committee to handle the buyback and it's subject to shareholder approval. Yes Securities (India) Limited will manage the buyback..
Frequently asked questions
What is the Incorporation or founding date of Jenburkt Pharmaceuticals Ltd?
Jenburkt Pharmaceuticals Ltd was incorporated on 10 Jun 1985.
What is authorized share capital and paid-up capital of Jenburkt Pharmaceuticals Ltd?
The authorized share capital of Jenburkt Pharmaceuticals Ltd is ₹ 10.00 Cr and paid-up capital is ₹ 4.41 Cr.
Who are the current board members & directors of Jenburkt Pharmaceuticals Ltd?
Currently 8 directors are associated with Jenburkt Pharmaceuticals Ltd.
- Ashish Rasiklal Shah
- Dilip Harkishandas Bhuta
- Hina Ravindra Mehta
- Dilip Harkishandas Bhuta
- Ashish Uttam Bhuta
- Krishnan Subharaman
- Pankaj Arun Dantwala
- Sumit Ajaybhai Thakkar
What is the registered address of Jenburkt Pharmaceuticals Ltd?
As per Ministry of Corporate Affairs (Mca), the registered address of Jenburkt Pharmaceuticals Ltd is Nirmala Apts 93 Jay Prakash Rd Andheri W India, Mumbai, Maharashtra, 400058.
What is the corporate identification number (CIN) and company number of Jenburkt Pharmaceuticals Ltd?
The corporate identification number (CIN) of Jenburkt Pharmaceuticals Ltd is L24230MH1985PLC036541 and the company number is 036541 as per Ministry of Corporate Affairs (MCA).
Is Jenburkt Pharmaceuticals Ltd registered with any stock exchange in India?
Yes, Jenburkt Pharmaceuticals Ltd is registered on Bombay Stock Exchange (BSE).
What is the official website of Jenburkt Pharmaceuticals Ltd?
The Official website of Jenburkt Pharmaceuticals Ltd is https://www.jenburkt.com
What has been the recent revenue trend for Jenburkt Pharmaceuticals Ltd?
According to the financial reports for the fiscal year 2023, the revenue trend for Jenburkt Pharmaceuticals Ltd has risen by 10.04%.
How many employees does Jenburkt Pharmaceuticals Ltd currently have?
As Per 2023 financial reports, 765 employees are currently employed by Jenburkt Pharmaceuticals Ltd.
What change has been observed in the net worth of Jenburkt Pharmaceuticals Ltd, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Jenburkt Pharmaceuticals Ltd has experienced an upsurge of 4.27%.
What are the total open charges for Jenburkt Pharmaceuticals Ltd?
As per the financial statements for fiscal Year 2023, The total open charges for Jenburkt Pharmaceuticals Ltd amount to ₹ 6.78 Cr.
When was the last Balance Sheet of Jenburkt Pharmaceuticals Ltd filed with the ROC?
The most recent Balance Sheet for Jenburkt Pharmaceuticals Ltd was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
UB
Uttam BhutaManaging DirectorBB
Bharat BhateDirectorHB
Harshad BhutaDirectorDS
Devangi ShahAdditional DirectorAS
Ashish ShahDirectorAR
Arun RaskapurwalaDirectorRV
Rameshchandra VoraDirectorAD
Anjali DalviDirector